Wednesday, July 8, 2026

Drug profile · INN

vasopressin

vasopressin (VASOPRESSIN) is a vasopressin receptor agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

FDA: approved NMPA: clinical trials
US status approved
Patents linked 7
Pipeline programs 5
News articles 0
Drug details — vasopressin
US status
approved
Class
Route
INJECTION
Patents
7
Programs
5
Data quality
0.89

Quick answer

vasopressin (VASOPRESSIN) is a vasopressin receptor agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

Key facts

INN vasopressin
Brand VASOPRESSIN
Mechanism Vasopressin receptor agonist
Target Vasopressin receptor
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Vasopressin receptor agonist

Primary target: Vasopressin receptor

Approval history

Authority Status Date
FDA approved
NMPA clinical trials

Pipeline programs

  1. 20200041 Phase 3 · Amgen · Extensive stage small cell lung cancer (ES-SCLC)
  2. 20230016 Phase 3 · Amgen · Limited-Stage Small-Cell Lung Cancer (LS SCLC)
  3. Early Vasopressin Phase 3 · Chongqing Precision Biotech · Septic Shock
  4. Vasopressin Phase 2 · United Therapeutics Europe · Traumatic Shock
  5. Intranasal Oxytocin (IN-OXT) Phase 1 · Tonix Pharmaceuticals Holding · Vasopressin Deficiency

Related & competitor drugs

  1. desmopressin acetate Vasopressin receptor agonist
  2. lypressin Vasopressin receptor agonist
  1. US 12247037

    1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives and related compounds as vasopressin antagonists for the treatment of neuro-psychological disorders

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12152038

    Vasopressin receptor antagonists and products and methods related thereto

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 11858943

    Vasopressin receptor antagonists and products and methods related thereto

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 11186577

    Vasopressin receptor antagonists and products and methods related thereto

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 10538530

    Vasopressin receptor antagonists and products and methods related thereto

    Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 10172911

    Methods of modulating erythropoiesis with arginine vasopressin receptor 1B molecules

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 9631001

    Peptide antagonists of the vasopressin-2 receptor

    Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is vasopressin?

vasopressin (VASOPRESSIN) is a vasopressin receptor agonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

What is the brand name for vasopressin?

VASOPRESSIN is a marketed brand name for vasopressin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of vasopressin?

vasopressin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.